Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
Nature. 2013 Aug 22;500(7463):415-21. doi: 10.1038/nature12477. Epub 2013 Aug 14.
All cancers are caused by somatic mutations; however, understanding of the biological processes generating these mutations is limited. The catalogue of somatic mutations from a cancer genome bears the signatures of the mutational processes that have been operative. Here we analysed 4,938,362 mutations from 7,042 cancers and extracted more than 20 distinct mutational signatures. Some are present in many cancer types, notably a signature attributed to the APOBEC family of cytidine deaminases, whereas others are confined to a single cancer class. Certain signatures are associated with age of the patient at cancer diagnosis, known mutagenic exposures or defects in DNA maintenance, but many are of cryptic origin. In addition to these genome-wide mutational signatures, hypermutation localized to small genomic regions, 'kataegis', is found in many cancer types. The results reveal the diversity of mutational processes underlying the development of cancer, with potential implications for understanding of cancer aetiology, prevention and therapy.
所有癌症都是由体细胞突变引起的;然而,人们对于产生这些突变的生物学过程的理解是有限的。癌症基因组中的体细胞突变目录带有已经起作用的突变过程的特征。在这里,我们分析了来自 7042 种癌症的 4938362 个突变,并提取了 20 多个不同的突变特征。有些特征存在于许多癌症类型中,特别是归因于 APOBEC 家族胞嘧啶脱氨酶的特征,而另一些则局限于单一的癌症类别。某些特征与患者在癌症诊断时的年龄、已知的诱变暴露或 DNA 维持缺陷有关,但许多特征是隐匿性的。除了这些全基因组突变特征外,在许多癌症类型中还发现了局部小基因组区域的超突变,即“kataegis”。这些结果揭示了癌症发生背后的多种突变过程,这可能对癌症病因学、预防和治疗的理解具有重要意义。